101. Urinary bladder hemangiosarcoma in a cat treated with partial cystectomy and adjuvant metronomic cyclophosphamide and thalidomide.
- Author
-
McNally A, Rossanese M, Suárez-Bonnet A, Hardas A, and Yale AD
- Subjects
- Male, Cats, Animals, Urinary Bladder surgery, Urinary Bladder pathology, Cystectomy veterinary, Thalidomide, Cyclophosphamide therapeutic use, Adjuvants, Immunologic, Hemangiosarcoma veterinary, Cat Diseases drug therapy, Cat Diseases surgery, Urinary Bladder Neoplasms drug therapy, Urinary Bladder Neoplasms surgery, Urinary Bladder Neoplasms veterinary
- Abstract
Visceral hemangiosarcomas (HSA) are rare in cats and typically associated with aggressive biologic behavior and poor prognosis. A 4-year-old male neutered domestic shorthair cat was presented with a 3-month history of hematuria and stranguria; ultrasonography identified a large bladder mass. Complete excision was achieved by partial cystectomy. Histopathology and immunohistochemistry for von Willebrand factor confirmed HSA. The cat was treated using adjuvant cyclophosphamide, thalidomide, and meloxicam for 8 months. Abdominal ultrasonography repeated at 2 months and computed tomography repeated at 5 and 19 months after diagnosis showed no evidence of local recurrence or metastasis. The cat was alive at last follow-up (896 days). Although the cat described in this report experienced a more favorable prognosis compared to other visceral HSA locations, additional cases are needed to further understand the biological behavior of bladder HSAs and guide treatment decisions., (© 2023 The Authors. Journal of Veterinary Internal Medicine published by Wiley Periodicals LLC on behalf of American College of Veterinary Internal Medicine.)
- Published
- 2023
- Full Text
- View/download PDF